COVIDH has officially confirmed the receipt of applications from nine specific investors for its rights issue on the opening date, November 3, 2025. This announcement comes in compliance with Regulation 77B(2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Key Details of the Rights Issue

The company disclosed that a total of 49,30,000 rights entitlements were applied for by the nine investors. The applications were submitted before 11:00 A.M. on the issue opening date, as required by regulations.

Breakdown of Applications

The following table provides a detailed breakdown of the applications received:

Regulatory Compliance

The company emphasized that these applications were made in compliance with the requirements of Regulation 77B(2) of the SEBI ICDR Regulations. This regulation pertains to the disclosure and confirmation of applications by specific investors in rights issues.

Additional Information

Covidh Technologies Limited's Letter of Offer for this rights issue is dated October 16, 2025. The company has made the complete details regarding the terms and process of application available on its website ( www.covidhtechnologies.com ) and on the website of BSE Limited.

Investors and stakeholders are advised to refer to these official documents for comprehensive information about the rights issue. The company's proactive disclosure aligns with regulatory requirements and demonstrates transparency in its capital raising process.

COVIDH has announced a significant rights issue, aiming to raise ₹8.09 crore through the issuance of new equity shares. The company's board of directors approved this corporate action in a meeting held on October 16, 2025, setting the stage for a substantial increase in its equity base.

Key Details of the Rights Issue

Timeline and Process

The rights issue is scheduled to open on November 3, 2025, and close on November 10, 2025. Shareholders listed in the company's records as of the record date (October 24, 2025) will be eligible to participate in this offering.

Impact on Share Capital

Covidh Technologies' equity structure is set for a significant transformation:

This represents a substantial increase in the company's outstanding shares, expanding over 26 times from the current level.

Rights Entitlements

In line with regulatory requirements, Covidh Technologies has arranged for the credit of Rights Entitlements (REs) in dematerialized form to the demat accounts of eligible shareholders. These entitlements will be credited prior to the issue opening date under the ISIN: INE899M20012.

Renunciation of Rights

Shareholders who do not wish to subscribe to their entitlements have the option to renounce them. The last date for on-market renunciation is November 4, 2025, while off-market renunciation can be done until November 10, 2025.

Conclusion

This rights issue represents a significant corporate action for Covidh Technologies, potentially impacting its capital structure and providing existing shareholders with an opportunity to increase their stake in the company. Investors are advised to carefully review the terms of the issue and consult financial advisors if needed before making investment decisions.